Clinical Liver Disease
Treatment options for anti-HCV treatment-experienced patients, Peter Ferenci - Article Reading
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:08:06
- Mas informaciones
Informações:
Sinopsis
Treatment failure with pegylated interferon (PEG-IFN)/ribavirin (RBV) dual therapy can be due to either the persistence of hepatitis C virus (HCV) RNA throughout treatment (nonresponse) or the reappearance of the virus after the end of treatment.